Gene expression profiling in bladder cancer identifies potential therapeutic targets

Syed A. Hussain, Daniel H. Palmer, Wing Kin Syn, Joseph J. Sacco, Richard M.D. Greensmith, Taha Elmetwali, Vijay Aachi, Bryony H. Lloyd, Puthen V. Jithesh, John Arrand, Darren Barton, Jawaher Ansari, D. Ross Sibson, Nicholas D. James

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Despite advances in management, bladder cancer remains a major cause of cancer related complications. Characterisation of gene expression patterns in bladder cancer allows the identification of pathways involved in its pathogenesis, and may stimulate the development of novel therapies targeting these pathways. Between 2004 and 2005, cystoscopic bladder biopsies were obtained from 19 patients and 11 controls. These were subjected to whole transcriptbased microarray analysis. Unsupervised hierarchical clustering was used to identify samples with similar expression profiles. Hypergeometric analysis was used to identify canonical pathways and curated networks having statistically significant enrichment of differentially expressed genes. Osteopontin (OPN) expression was validated by immunohistochemistry. Hierarchical clustering defined signatures, which differentiated between cancer and healthy tissue, muscle-invasive or non-muscle invasive cancer and healthy tissue, grade 1 and grade 3. Pathways associated with cell cycle and proliferation were markedly upregulated in muscle-invasive and grade 3 cancers. Genes associated with the classical complement pathway were downregulated in non-muscle invasive cancer. Osteopontin was markedly overexpressed in invasive cancer compared to healthy tissue. The present study contributes to a growing body of work on gene expression signatures in bladder cancer. The data support an important role for osteopontin in bladder cancer, and identify several pathways worthy of further investigation.

Original languageEnglish
Pages (from-to)1147-1159
Number of pages13
JournalInternational Journal of Oncology
Volume50
Issue number4
DOIs
Publication statusPublished - 1 Apr 2017
Externally publishedYes

Fingerprint

Gene Expression Profiling
Urinary Bladder Neoplasms
Osteopontin
Neoplasms
Cluster Analysis
Therapeutics
Classical Complement Pathway
Muscles
Microarray Analysis
Transcriptome
Genes
Cell Cycle
Urinary Bladder
Down-Regulation
Immunohistochemistry
Cell Proliferation
Biopsy
Gene Expression

Keywords

  • Bladder cancer
  • Gene expression analysis
  • Microarray
  • Molecular classification
  • Muscle invasive
  • Osteopontin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hussain, S. A., Palmer, D. H., Syn, W. K., Sacco, J. J., Greensmith, R. M. D., Elmetwali, T., ... James, N. D. (2017). Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology, 50(4), 1147-1159. https://doi.org/10.3892/ijo.2017.3893

Gene expression profiling in bladder cancer identifies potential therapeutic targets. / Hussain, Syed A.; Palmer, Daniel H.; Syn, Wing Kin; Sacco, Joseph J.; Greensmith, Richard M.D.; Elmetwali, Taha; Aachi, Vijay; Lloyd, Bryony H.; Jithesh, Puthen V.; Arrand, John; Barton, Darren; Ansari, Jawaher; Sibson, D. Ross; James, Nicholas D.

In: International Journal of Oncology, Vol. 50, No. 4, 01.04.2017, p. 1147-1159.

Research output: Contribution to journalArticle

Hussain, SA, Palmer, DH, Syn, WK, Sacco, JJ, Greensmith, RMD, Elmetwali, T, Aachi, V, Lloyd, BH, Jithesh, PV, Arrand, J, Barton, D, Ansari, J, Sibson, DR & James, ND 2017, 'Gene expression profiling in bladder cancer identifies potential therapeutic targets', International Journal of Oncology, vol. 50, no. 4, pp. 1147-1159. https://doi.org/10.3892/ijo.2017.3893
Hussain SA, Palmer DH, Syn WK, Sacco JJ, Greensmith RMD, Elmetwali T et al. Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology. 2017 Apr 1;50(4):1147-1159. https://doi.org/10.3892/ijo.2017.3893
Hussain, Syed A. ; Palmer, Daniel H. ; Syn, Wing Kin ; Sacco, Joseph J. ; Greensmith, Richard M.D. ; Elmetwali, Taha ; Aachi, Vijay ; Lloyd, Bryony H. ; Jithesh, Puthen V. ; Arrand, John ; Barton, Darren ; Ansari, Jawaher ; Sibson, D. Ross ; James, Nicholas D. / Gene expression profiling in bladder cancer identifies potential therapeutic targets. In: International Journal of Oncology. 2017 ; Vol. 50, No. 4. pp. 1147-1159.
@article{1c8d185d5e024318841c7cdce82110c8,
title = "Gene expression profiling in bladder cancer identifies potential therapeutic targets",
abstract = "Despite advances in management, bladder cancer remains a major cause of cancer related complications. Characterisation of gene expression patterns in bladder cancer allows the identification of pathways involved in its pathogenesis, and may stimulate the development of novel therapies targeting these pathways. Between 2004 and 2005, cystoscopic bladder biopsies were obtained from 19 patients and 11 controls. These were subjected to whole transcriptbased microarray analysis. Unsupervised hierarchical clustering was used to identify samples with similar expression profiles. Hypergeometric analysis was used to identify canonical pathways and curated networks having statistically significant enrichment of differentially expressed genes. Osteopontin (OPN) expression was validated by immunohistochemistry. Hierarchical clustering defined signatures, which differentiated between cancer and healthy tissue, muscle-invasive or non-muscle invasive cancer and healthy tissue, grade 1 and grade 3. Pathways associated with cell cycle and proliferation were markedly upregulated in muscle-invasive and grade 3 cancers. Genes associated with the classical complement pathway were downregulated in non-muscle invasive cancer. Osteopontin was markedly overexpressed in invasive cancer compared to healthy tissue. The present study contributes to a growing body of work on gene expression signatures in bladder cancer. The data support an important role for osteopontin in bladder cancer, and identify several pathways worthy of further investigation.",
keywords = "Bladder cancer, Gene expression analysis, Microarray, Molecular classification, Muscle invasive, Osteopontin",
author = "Hussain, {Syed A.} and Palmer, {Daniel H.} and Syn, {Wing Kin} and Sacco, {Joseph J.} and Greensmith, {Richard M.D.} and Taha Elmetwali and Vijay Aachi and Lloyd, {Bryony H.} and Jithesh, {Puthen V.} and John Arrand and Darren Barton and Jawaher Ansari and Sibson, {D. Ross} and James, {Nicholas D.}",
year = "2017",
month = "4",
day = "1",
doi = "10.3892/ijo.2017.3893",
language = "English",
volume = "50",
pages = "1147--1159",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Gene expression profiling in bladder cancer identifies potential therapeutic targets

AU - Hussain, Syed A.

AU - Palmer, Daniel H.

AU - Syn, Wing Kin

AU - Sacco, Joseph J.

AU - Greensmith, Richard M.D.

AU - Elmetwali, Taha

AU - Aachi, Vijay

AU - Lloyd, Bryony H.

AU - Jithesh, Puthen V.

AU - Arrand, John

AU - Barton, Darren

AU - Ansari, Jawaher

AU - Sibson, D. Ross

AU - James, Nicholas D.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Despite advances in management, bladder cancer remains a major cause of cancer related complications. Characterisation of gene expression patterns in bladder cancer allows the identification of pathways involved in its pathogenesis, and may stimulate the development of novel therapies targeting these pathways. Between 2004 and 2005, cystoscopic bladder biopsies were obtained from 19 patients and 11 controls. These were subjected to whole transcriptbased microarray analysis. Unsupervised hierarchical clustering was used to identify samples with similar expression profiles. Hypergeometric analysis was used to identify canonical pathways and curated networks having statistically significant enrichment of differentially expressed genes. Osteopontin (OPN) expression was validated by immunohistochemistry. Hierarchical clustering defined signatures, which differentiated between cancer and healthy tissue, muscle-invasive or non-muscle invasive cancer and healthy tissue, grade 1 and grade 3. Pathways associated with cell cycle and proliferation were markedly upregulated in muscle-invasive and grade 3 cancers. Genes associated with the classical complement pathway were downregulated in non-muscle invasive cancer. Osteopontin was markedly overexpressed in invasive cancer compared to healthy tissue. The present study contributes to a growing body of work on gene expression signatures in bladder cancer. The data support an important role for osteopontin in bladder cancer, and identify several pathways worthy of further investigation.

AB - Despite advances in management, bladder cancer remains a major cause of cancer related complications. Characterisation of gene expression patterns in bladder cancer allows the identification of pathways involved in its pathogenesis, and may stimulate the development of novel therapies targeting these pathways. Between 2004 and 2005, cystoscopic bladder biopsies were obtained from 19 patients and 11 controls. These were subjected to whole transcriptbased microarray analysis. Unsupervised hierarchical clustering was used to identify samples with similar expression profiles. Hypergeometric analysis was used to identify canonical pathways and curated networks having statistically significant enrichment of differentially expressed genes. Osteopontin (OPN) expression was validated by immunohistochemistry. Hierarchical clustering defined signatures, which differentiated between cancer and healthy tissue, muscle-invasive or non-muscle invasive cancer and healthy tissue, grade 1 and grade 3. Pathways associated with cell cycle and proliferation were markedly upregulated in muscle-invasive and grade 3 cancers. Genes associated with the classical complement pathway were downregulated in non-muscle invasive cancer. Osteopontin was markedly overexpressed in invasive cancer compared to healthy tissue. The present study contributes to a growing body of work on gene expression signatures in bladder cancer. The data support an important role for osteopontin in bladder cancer, and identify several pathways worthy of further investigation.

KW - Bladder cancer

KW - Gene expression analysis

KW - Microarray

KW - Molecular classification

KW - Muscle invasive

KW - Osteopontin

UR - http://www.scopus.com/inward/record.url?scp=85018469998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018469998&partnerID=8YFLogxK

U2 - 10.3892/ijo.2017.3893

DO - 10.3892/ijo.2017.3893

M3 - Article

VL - 50

SP - 1147

EP - 1159

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -